期刊
REDOX BIOLOGY
卷 62, 期 -, 页码 -出版社
ELSEVIER
DOI: 10.1016/j.redox.2023.102661
关键词
Hematopoietic stem cell; Cholesterol; Ferroptosis; Myeloid bias; Ionizing radiation; Myelosuppression
There is a growing understanding of the role of hematopoietic alterations in the detrimental effects of metabolic disorders. This study reveals that hematopoietic stem cells in the bone marrow have distinct cholesterol metabolic signatures and that cholesterol directly regulates their maintenance and lineage differentiation. The study also uncovers the mechanisms by which cholesterol enhances ferroptosis resistance and promotes myeloid lineage differentiation while dampening lymphoid lineage differentiation. These findings have important clinical implications for understanding and treating metabolic disorders.
There is growing appreciation that hematopoietic alterations underpin the ubiquitous detrimental effects of metabolic disorders. The susceptibility of bone marrow (BM) hematopoiesis to perturbations of cholesterol metabolism is well documented, while the underlying cellular and molecular mechanisms remain poorly un-derstood. Here we reveal a distinct and heterogeneous cholesterol metabolic signature within BM hematopoietic stem cells (HSCs). We further show that cholesterol directly regulates maintenance and lineage differentiation of long-term HSCs (LT-HSCs), with high levels of intracellular cholesterol favoring maintenance and myeloid bias of LT-HSCs. During irradiation-induced myelosuppression, cholesterol also safeguards LT-HSC maintenance and myeloid regeneration. Mechanistically, we unravel that cholesterol directly and distinctively enhances ferrop-tosis resistance and boosts myeloid but dampens lymphoid lineage differentiation of LT-HSCs. Molecularly, we identify that SLC38A9-mTOR axis mediates cholesterol sensing and signal transduction to instruct lineage dif-ferentiation of LT-HSCs as well as to dictate ferroptosis sensitivity of LT-HSCs through orchestrating SLC7A11/ GPX4 expression and ferritinophagy. Consequently, myeloid-biased HSCs are endowed with a survival advantage under both hypercholesterolemia and irradiation conditions. Importantly, a mTOR inhibitor rapamycin and a ferroptosis inducer imidazole ketone erastin prevent excess cholesterol-induced HSC expansion and myeloid bias. These findings unveil an unrecognized fundamental role of cholesterol metabolism in HSC survival and fate decisions with valuable clinical implications.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据